How long should I keep giving anticonvulsant medications to a child with benign genetic epilepsy?
How long should I keep giving anticonvulsant medications to a child with benign genetic epilepsy?
----MD
Benign epilepsies of childhood are seizure disorders that occur in normally developing children with no recognized brain insult. Most children with one of the benign epilepsies have seizures that are easily controlled, and many are able to eventually discontinue antiseizure medication without seizure recurrence.
"Benign epilepsy of childhood with central temporal spikes" (BECTS, or Rolandic epilepsy) is the best-recognized benign epilepsy that primary care physicians are likely to encounter. Onset is usually between 3 and 13 years.1 Seizures usually begin as the child is awakening from sleep, with facial sensation changes or motor symptoms; however, it is the secondarily generalized seizure that parents usually hear and respond to. Thus, the "partial" nature of the seizures is often not recognized until after an electroencephalogram (EEG) is obtained. The EEG in patients with BECTS characteristically shows sleep-activated epileptiform spike discharges in the central-temporal region. Other benign epilepsies of childhood are less well characterized.
Most pediatric neurologists treat children with benign epilepsy for 2 years. In general, if a child has been seizure-free for 1 to 4 years, the likelihood that stopping antiseizure medication will be successful (ie, there is no recurrence of seizures) is approximately 70%.2,3 However, if seizures do recur while antiepileptic medication is being tapered--or after its discontinuation--treatment is restarted and continued for another 2 years. It is important to remind parents about seizure precautions (eg, do not leave a child with a history of seizures unattended in a bathtub or hot tub) and seizure first aid before tapering antiseizure medications.
----Donald M. Olson, MD
Associate Professor of Neurology and Pediatrics
Stanford University Medical Center
Palo Alto, Calif
REFERENCES:
1. Guerrini R. Epilepsy in children.
Lancet.
2006;367:499-524.
2. Camfield CS, Camfield PR, Gordon KE, et al. Predicting the outcome of childhood epilepsy: a population-based study yielding a simple scoring system.
J Pediatr.
1993;122:861-868.
3. Shinnar S, Berg AT, O'Dell C, et al. Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure.
Ann Neurol.
2000;48:140-147.
Seizures could be the cause of many sudden unexplained deaths in toddlers
January 9th 2024The study authors noted that without video evidence, seizures would not have been implicated in death investigations and that seizure-related deaths are underrecognized in patients with epilepsy and in those without.
FDA warns of serious potential reaction to levetiracetam and clobazam
November 30th 2023The reaction, called Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), can start as a rash but can progress quickly, potentially resulting in injury to internal organs, hospitalization, and death.
Dietary therapies safe and efficient for treating drug-resistant epilepsy
February 7th 2023While treatment discontinuation because of adverse events was more likely when taking dietary therapies for treating childhood drug-resistant epilepsy, reduction of seizures and seizure freedom were significantly more common.
First patient treated in adolescent epilepsy trial assessing NeuroPace RNS system
May 17th 2022Since its approval for the treatment of medical refractory epilepsy in 2013, the closed-loop neuromodulation device has had its efficacy and safety confirmed in several pivotal studies and will now be assessed in focal epilepsy in the RESPONSE trial.